-
1
-
-
0027423419
-
Role of insulin-like growth factors in embryonic and postnatal growth
-
Baker, J., J.P. Liu, E.J. Robertson, and A. Efstratiadis. 1993. Role of insulin-like growth factors in embryonic and postnatal growth. Cell. 75:73-82.
-
(1993)
Cell
, vol.75
, pp. 73-82
-
-
Baker, J.1
Liu, J.P.2
Robertson, E.J.3
Efstratiadis, A.4
-
2
-
-
0028957113
-
Molecular and cellular aspects of the insulin-like growth factor I receptor
-
LeRoith, D., H. Werner. D. Beitner-Johnson, and C. Roberts. 1995. Molecular and cellular aspects of the insulin-like growth factor I receptor. Endocr. Rev. 16:143-163.
-
(1995)
Endocr. Rev.
, vol.16
, pp. 143-163
-
-
LeRoith, D.1
Werner, H.2
Beitner-Johnson, D.3
Roberts, C.4
-
3
-
-
0030015606
-
Insulin-like growth factor-I in the therapy of non-insulin-dependent diabetes mellitus and insulin resistance
-
Froesch, E.R., T. Bianda, and M.A. Hussain. 1996. Insulin-like growth factor-I in the therapy of non-insulin-dependent diabetes mellitus and insulin resistance. Diabetes Metab. 22:261-267.
-
(1996)
Diabetes Metab.
, vol.22
, pp. 261-267
-
-
Froesch, E.R.1
Bianda, T.2
Hussain, M.A.3
-
4
-
-
0023276184
-
Short-term metabolic effects of recombinant human insulin-like growth factor I in healthy adults
-
Guler, H.P., J. Zapf, and E.R. Froesch. 1987. Short-term metabolic effects of recombinant human insulin-like growth factor I in healthy adults. N. Engl. J. Med. 317:137-140.
-
(1987)
N. Engl. J. Med.
, vol.317
, pp. 137-140
-
-
Guler, H.P.1
Zapf, J.2
Froesch, E.R.3
-
5
-
-
0027932978
-
Beneficial metabolic effects of insulin-like growth factor I in patients with severe insulin-resistant diabetes type A
-
Zenobi, P.D., Y. Glatz, A. Keller, S. Graf, G.S. Jaeggi, W.F. Riesen, E.J. Schoenle, and E.R. Froesch. 1994. Beneficial metabolic effects of insulin-like growth factor I in patients with severe insulin-resistant diabetes type A. Eur. J. Endocrinol. 131:251-257.
-
(1994)
Eur. J. Endocrinol.
, vol.131
, pp. 251-257
-
-
Zenobi, P.D.1
Glatz, Y.2
Keller, A.3
Graf, S.4
Jaeggi, G.S.5
Riesen, W.F.6
Schoenle, E.J.7
Froesch, E.R.8
-
6
-
-
0029082168
-
Insulin-like growth factor I (rhIGF-I) as a therapeutic agent for hyperinsulinemic insulin-resistant diabetes mellitus
-
Moses, A.C., L.A. Morrow, M. O'Brien, D.E. Moller, and J.S. Flier. 1995. Insulin-like growth factor I (rhIGF-I) as a therapeutic agent for hyperinsulinemic insulin-resistant diabetes mellitus. Diabetes Res. Clin. Pract. 28(Suppl. 1): 185-194.
-
(1995)
Diabetes Res. Clin. Pract.
, vol.28
, Issue.1 SUPPL.
, pp. 185-194
-
-
Moses, A.C.1
Morrow, L.A.2
O'Brien, M.3
Moller, D.E.4
Flier, J.S.5
-
7
-
-
0030032795
-
Recombinant human insulin-like growth factor I increases insulin sensitivity and improves glycemic control in type II diabetes
-
Moses, A.C., S.C. Young, L.A. Morrow, M. O'Brien, and D.R. Clemmons. 1996. Recombinant human insulin-like growth factor I increases insulin sensitivity and improves glycemic control in type II diabetes. Diabetes. 45: 91-100.
-
(1996)
Diabetes
, vol.45
, pp. 91-100
-
-
Moses, A.C.1
Young, S.C.2
Morrow, L.A.3
O'Brien, M.4
Clemmons, D.R.5
-
8
-
-
0028300538
-
Recombinant human insulin-like growth factor-I therapy improves glycemic control and insulin action in the type A syndrome of severe insulin resistance
-
Morrow, L.A., M.B. O'Brien, D.E. Moller, J.S. Flier, and A.C. Moses. 1994. Recombinant human insulin-like growth factor-I therapy improves glycemic control and insulin action in the type A syndrome of severe insulin resistance. J. Clin. Endocrinol. Metab. 79:205-210.
-
(1994)
J. Clin. Endocrinol. Metab.
, vol.79
, pp. 205-210
-
-
Morrow, L.A.1
O'Brien, M.B.2
Moller, D.E.3
Flier, J.S.4
Moses, A.C.5
-
9
-
-
0028324350
-
Clinical uses of insulin-like growth factor I
-
Bondy, C.A., L.E. Underwood, D.R. Clemmons, H.P. Guler, M.A. Bach, and M. Skarulis. 1994. Clinical uses of insulin-like growth factor I. Ann. Intern. Med. 120:593-601.
-
(1994)
Ann. Intern. Med.
, vol.120
, pp. 593-601
-
-
Bondy, C.A.1
Underwood, L.E.2
Clemmons, D.R.3
Guler, H.P.4
Bach, M.A.5
Skarulis, M.6
-
10
-
-
0027502045
-
Purified hybrid insulin/insulin-like growth factor-I receptors bind insulin-like growth factor-I, but not insulin, with high affinity
-
Soos, M.A., C.E. Field, and K. Siddle. 1993. Purified hybrid insulin/insulin-like growth factor-I receptors bind insulin-like growth factor-I, but not insulin, with high affinity. Biochem. J. 290:419-426.
-
(1993)
Biochem. J.
, vol.290
, pp. 419-426
-
-
Soos, M.A.1
Field, C.E.2
Siddle, K.3
-
11
-
-
0027773113
-
Molecular properties of insulin/IGF-1 hybrid receptors
-
4th International Symposium on Insulin. IGFs and their Receptors
-
Pessin, J.E. 1993. Molecular properties of insulin/IGF-1 hybrid receptors. 4th International Symposium on Insulin. IGFs and their Receptors. Adv. Exp. Med. Biol. 343:133-144.
-
(1993)
Adv. Exp. Med. Biol.
, vol.343
, pp. 133-144
-
-
Pessin, J.E.1
-
12
-
-
0026528956
-
Insulin/IGF-1 hybrid receptors: Implications for the dominant-negative phenotype in syndromes of insulin resistance
-
Frattali, A.L., J.L. Treadway, and J.E. Pessin. 1992. Insulin/IGF-1 hybrid receptors: implications for the dominant-negative phenotype in syndromes of insulin resistance. J. Cell. Biochem. 48:43-50.
-
(1992)
J. Cell. Biochem.
, vol.48
, pp. 43-50
-
-
Frattali, A.L.1
Treadway, J.L.2
Pessin, J.E.3
-
13
-
-
0026053772
-
Transdominant inhibition of tyrosine kinase activity in mutant insulin/insulin-like growth factor I hybrid receptors
-
Treadway, J.L., B.D. Morrison, M.A. Soos, K. Siddle, J. Olefsky, A. Ullrich, D.A. McClain, and J.E. Pessin. 1991. Transdominant inhibition of tyrosine kinase activity in mutant insulin/insulin-like growth factor I hybrid receptors. Proc. Natl. Acad. Sci. USA. 88:214-218.
-
(1991)
Proc. Natl. Acad. Sci. USA
, vol.88
, pp. 214-218
-
-
Treadway, J.L.1
Morrison, B.D.2
Soos, M.A.3
Siddle, K.4
Olefsky, J.5
Ullrich, A.6
McClain, D.A.7
Pessin, J.E.8
-
14
-
-
0028904053
-
Insulin action and the insulin signaling network
-
Cheatham, B., and C.R. Kahn. 1995. Insulin action and the insulin signaling network. Endocr. Rev. 16:117-142.
-
(1995)
Endocr. Rev.
, vol.16
, pp. 117-142
-
-
Cheatham, B.1
Kahn, C.R.2
-
15
-
-
0028151904
-
Comparative effects of IGF-I and insulin on the glucose transporter system in rat muscle
-
Lund, S., A. Flyvbjerg, G.D. Holman, F.S. Larsen, O. Pedersen, and O. Schmilz. 1994. Comparative effects of IGF-I and insulin on the glucose transporter system in rat muscle. Am. J. Physiol. 267:E461-E466.
-
(1994)
Am. J. Physiol.
, vol.267
-
-
Lund, S.1
Flyvbjerg, A.2
Holman, G.D.3
Larsen, F.S.4
Pedersen, O.5
Schmilz, O.6
-
16
-
-
0021343264
-
The type I insulin-like growth factor receptor mediates the rapid effects of multiplication-stimulating activity on membrane transport systems in rat soleus muscle
-
Yu, K.T., and M.P. Czech. 1984. The type I insulin-like growth factor receptor mediates the rapid effects of multiplication-stimulating activity on membrane transport systems in rat soleus muscle. J. Biol. Chem. 259:3090-3095.
-
(1984)
J. Biol. Chem.
, vol.259
, pp. 3090-3095
-
-
Yu, K.T.1
Czech, M.P.2
-
17
-
-
0018650188
-
Effects and binding of insulin-like growth factor I in the isolated soleus muscle of lean and obese mice: Comparison with insulin
-
Poggi, C., M. Le, Y. Brustel, J. Zapf, E.R. Froesch, and P. Freychet. 1979. Effects and binding of insulin-like growth factor I in the isolated soleus muscle of lean and obese mice: comparison with insulin. Endocrinology. 105: 723-730.
-
(1979)
Endocrinology
, vol.105
, pp. 723-730
-
-
Poggi, C.1
Le, M.2
Brustel, Y.3
Zapf, J.4
Froesch, E.R.5
Freychet, P.6
-
18
-
-
0025937729
-
IGF-I mediated recruitment of glucose transporters from intracellular membranes to plasma membranes in L6 muscle cells
-
Bilan, P.J., T. Ramlal, and A. Klip. 1991. IGF-I mediated recruitment of glucose transporters from intracellular membranes to plasma membranes in L6 muscle cells. Adv. Exp. Med. Biol. 293:273-288.
-
(1991)
Adv. Exp. Med. Biol.
, vol.293
, pp. 273-288
-
-
Bilan, P.J.1
Ramlal, T.2
Klip, A.3
-
19
-
-
0028036698
-
Insulin receptor substrate-1 mediates phosphatidylinositol 3′-kinase and p70S6k signaling during insulin, insulin-like growth factor-1, and interleukin-4 stimulation
-
Myers, M.J., T.C. Grammer, L.M. Wang, X.J. Sun, J.H. Pierce, J. Blenis, and M.F. White. 1994. Insulin receptor substrate-1 mediates phosphatidylinositol 3′-kinase and p70S6k signaling during insulin, insulin-like growth factor-1, and interleukin-4 stimulation. J. Biol. Chem. 269:28783-28789.
-
(1994)
J. Biol. Chem.
, vol.269
, pp. 28783-28789
-
-
Myers, M.J.1
Grammer, T.C.2
Wang, L.M.3
Sun, X.J.4
Pierce, J.H.5
Blenis, J.6
White, M.F.7
-
20
-
-
0027516706
-
IRS-1 is a common element in insulin and insulin-like growth factor-I signaling to the phosphatidylinositol 3′-kinase
-
Myers, M.J., X.J. Sun, B. Cheatham, B.R. Jachna, E.M. Glasheen, J.M. Backer, and M.F. White. 1993. IRS-1 is a common element in insulin and insulin-like growth factor-I signaling to the phosphatidylinositol 3′-kinase. Endocrinology. 132:1421-1430.
-
(1993)
Endocrinology
, vol.132
, pp. 1421-1430
-
-
Myers, M.J.1
Sun, X.J.2
Cheatham, B.3
Jachna, B.R.4
Glasheen, E.M.5
Backer, J.M.6
White, M.F.7
-
21
-
-
13344277357
-
Early neonatal death in mice homozygous for a null allele of the insulin receptor gene
-
Accili, D., J. Drago, E.J. Lee, M.D. Johnson, M.H. Cool, P. Salvatore, L.D. Asico, P.A. Jose, S.I. Taylor, and H. Westphal. 1996. Early neonatal death in mice homozygous for a null allele of the insulin receptor gene. Nat. Genet. 12: 106-109.
-
(1996)
Nat. Genet.
, vol.12
, pp. 106-109
-
-
Accili, D.1
Drago, J.2
Lee, E.J.3
Johnson, M.D.4
Cool, M.H.5
Salvatore, P.6
Asico, L.D.7
Jose, P.A.8
Taylor, S.I.9
Westphal, H.10
-
22
-
-
0029879127
-
Targeted disruption of the insulin receptor gene in the mouse results in neonatal lethality
-
Joshi, R.L., B. Lamothe, N. Cordonnier, K. Mesbah, E. Monthioux, J. Jami, and D. Bucchini. 1996. Targeted disruption of the insulin receptor gene in the mouse results in neonatal lethality. EMBO (Eur. Mol. Biol. Organ.) J. 15: 1542-1547.
-
(1996)
EMBO (Eur. Mol. Biol. Organ.) J.
, vol.15
, pp. 1542-1547
-
-
Joshi, R.L.1
Lamothe, B.2
Cordonnier, N.3
Mesbah, K.4
Monthioux, E.5
Jami, J.6
Bucchini, D.7
-
23
-
-
0026656320
-
Lilly Lecture: Molecular mechanisms of insulin resistance. Lessons from patients with mutations in the insulin-receptor gene
-
Taylor, S.I. 1992. Lilly Lecture: molecular mechanisms of insulin resistance. Lessons from patients with mutations in the insulin-receptor gene. Diabetes. 41:1473-1490.
-
(1992)
Diabetes
, vol.41
, pp. 1473-1490
-
-
Taylor, S.I.1
-
24
-
-
0028903027
-
Molecular defects of the insulin receptor gene
-
Accili, D. 1995. Molecular defects of the insulin receptor gene. Diabetes. Metab. Rev. 11:47-62.
-
(1995)
Diabetes. Metab. Rev.
, vol.11
, pp. 47-62
-
-
Accili, D.1
-
25
-
-
0021893848
-
Establishment of rat fetal liver lines and characterization of their metabolic and hormonal properties: Use of temperature-sensitive SV40 virus
-
Chou, J.Y. 1985. Establishment of rat fetal liver lines and characterization of their metabolic and hormonal properties: use of temperature-sensitive SV40 virus. Methods Emzymol. 109:385-396.
-
(1985)
Methods Emzymol.
, vol.109
, pp. 385-396
-
-
Chou, J.Y.1
-
26
-
-
0022214778
-
Rat hepatic cytosolic phosphoenolpyruvate carboxykinase (GTP). Structures of the protein, messenger RNA, and gene
-
Beale, E.G., N.B. Chrapkiewicz, H.A. Scoble, R.J. Metz, D.P. Quick, R.L. Noble, J.E. Donelson, K. Biemann, and D.K. Granner. 1985. Rat hepatic cytosolic phosphoenolpyruvate carboxykinase (GTP). Structures of the protein, messenger RNA, and gene. J. Biol. Chem. 260:10748-10760.
-
(1985)
J. Biol. Chem.
, vol.260
, pp. 10748-10760
-
-
Beale, E.G.1
Chrapkiewicz, N.B.2
Scoble, H.A.3
Metz, R.J.4
Quick, D.P.5
Noble, R.L.6
Donelson, J.E.7
Biemann, K.8
Granner, D.K.9
-
27
-
-
0027441948
-
Cloning of cDNA for the alpha subunit of mouse insulin-like growth factor I receptor and the role of the receptor in metanephric development
-
Wada, J., Z.Z. Liu, K. Alvares, A. Kumar, E. Wallner, H. Makino, and Y.S. Kanwar. 1993. Cloning of cDNA for the alpha subunit of mouse insulin-like growth factor I receptor and the role of the receptor in metanephric development. Proc. Natl. Acad. Sci. USA. 90:10360-10364.
-
(1993)
Proc. Natl. Acad. Sci. USA
, vol.90
, pp. 10360-10364
-
-
Wada, J.1
Liu, Z.Z.2
Alvares, K.3
Kumar, A.4
Wallner, E.5
Makino, H.6
Kanwar, Y.S.7
-
28
-
-
0025273872
-
Identification and characterization of a rat decidual insulin-like growth factor-binding protein complementary DNA
-
Murphy, L.J., C. Seneviratne, G. Ballejo, F. Croze, and T.G. Kennedy. 1990. Identification and characterization of a rat decidual insulin-like growth factor-binding protein complementary DNA. Mol. Endocrinol. 4:329-336.
-
(1990)
Mol. Endocrinol.
, vol.4
, pp. 329-336
-
-
Murphy, L.J.1
Seneviratne, C.2
Ballejo, G.3
Croze, F.4
Kennedy, T.G.5
-
29
-
-
0026482002
-
Regulation of rat insulin-like growth factor-binding protein-1: The effect of insulin-induced hypoglycemia
-
Lewitt, M.S., H. Saunders, and R.C. Baxter. 1992. Regulation of rat insulin-like growth factor-binding protein-1: the effect of insulin-induced hypoglycemia. Endocrinology. 131:2357-2364.
-
(1992)
Endocrinology
, vol.131
, pp. 2357-2364
-
-
Lewitt, M.S.1
Saunders, H.2
Baxter, R.C.3
-
30
-
-
0027051126
-
Insulin rapidly decreases insulin-like growth factor-binding protein-1 gene transcription in streptozotocin-diabetic rats
-
Ooi, G.T., L.Y. Tseng, M.Q. Tran, and M.M. Rechler. 1992. Insulin rapidly decreases insulin-like growth factor-binding protein-1 gene transcription in streptozotocin-diabetic rats. Mol. Endocrinol. 6:2219-2228.
-
(1992)
Mol. Endocrinol.
, vol.6
, pp. 2219-2228
-
-
Ooi, G.T.1
Tseng, L.Y.2
Tran, M.Q.3
Rechler, M.M.4
-
31
-
-
0027416751
-
Association of IRS-1 with the insulin receptor and the phosphatidylinositol 3′-kinase. Formation of binary and ternary signaling complexes in intact cells
-
Backer, J.M., M.J. Myers, X.J. Sun, D.J. Chin, S.E. Shoelson, M. Miralpeix, and M.F. White. 1993. Association of IRS-1 with the insulin receptor and the phosphatidylinositol 3′-kinase. Formation of binary and ternary signaling complexes in intact cells. J. Biol. Chem. 268:8204-8212.
-
(1993)
J. Biol. Chem.
, vol.268
, pp. 8204-8212
-
-
Backer, J.M.1
Myers, M.J.2
Sun, X.J.3
Chin, D.J.4
Shoelson, S.E.5
Miralpeix, M.6
White, M.F.7
-
32
-
-
0026489451
-
IRS-1 activates phosphatidylinositol 3′-kinase by associating with src homology 2 domains of p85
-
Myers, M.J., J.M. Backer, X.J. Sun, S. Shoelson, P. Hu, J. Schlessinger, M. Yoakim, B. Schaffhausen, and M.F. White. 1992. IRS-1 activates phosphatidylinositol 3′-kinase by associating with src homology 2 domains of p85. Proc. Natl. Acad. Sci. USA. 89:10350-10354.
-
(1992)
Proc. Natl. Acad. Sci. USA
, vol.89
, pp. 10350-10354
-
-
Myers, M.J.1
Backer, J.M.2
Sun, X.J.3
Shoelson, S.4
Hu, P.5
Schlessinger, J.6
Yoakim, M.7
Schaffhausen, B.8
White, M.F.9
-
33
-
-
0028157728
-
The IRS-1 signaling system
-
White, M.F. 1994. The IRS-1 signaling system. Curr. Opin. Genet. Dev. 4:47-54.
-
(1994)
Curr. Opin. Genet. Dev.
, vol.4
, pp. 47-54
-
-
White, M.F.1
-
34
-
-
0028124189
-
Essential role of phosphatidylinositol 3-kinase in insulin-induced glucose transport and antilipolysis in rat adipocytes. Studies with a selective inhibitor wortmannin
-
Okada, T., Y. Kawano, T. Sakakibara, O. Hazeki, and M. Ui. 1994. Essential role of phosphatidylinositol 3-kinase in insulin-induced glucose transport and antilipolysis in rat adipocytes. Studies with a selective inhibitor wortmannin. J. Biol. Chem. 269:3568-3573.
-
(1994)
J. Biol. Chem.
, vol.269
, pp. 3568-3573
-
-
Okada, T.1
Kawano, Y.2
Sakakibara, T.3
Hazeki, O.4
Ui, M.5
-
35
-
-
0026660653
-
The phosphatidylinositol 3′-kinase is activated by association with IRS-1 during insulin stimulation
-
Backer, J., M. Myers, S. Shoelson, D. Chin, X. Sun, M. Miralpeix, P. Hu, B. Margolis, E. Skolnik, J. Schlessinger, and M. White. 1992. The phosphatidylinositol 3′-kinase is activated by association with IRS-1 during insulin stimulation. EMBO (Eur. Mol. Biol. Organ.) J. 11:3469-3479.
-
(1992)
EMBO (Eur. Mol. Biol. Organ.) J.
, vol.11
, pp. 3469-3479
-
-
Backer, J.1
Myers, M.2
Shoelson, S.3
Chin, D.4
Sun, X.5
Miralpeix, M.6
Hu, P.7
Margolis, B.8
Skolnik, E.9
Schlessinger, J.10
White, M.11
-
36
-
-
0025813375
-
Structure of the insulin receptor substrate IRS-1 defines a unique signal transduction protein
-
Sun, X.J., P. Rothenberg, C.R. Kahn, J.M. Backer, E. Araki, P.A. Wilden, D.A. Cahill, B.J. Goldstein, and M.F. White. 1991. Structure of the insulin receptor substrate IRS-1 defines a unique signal transduction protein. Nature (Lond.). 352:73-77.
-
(1991)
Nature (Lond.)
, vol.352
, pp. 73-77
-
-
Sun, X.J.1
Rothenberg, P.2
Kahn, C.R.3
Backer, J.M.4
Araki, E.5
Wilden, P.A.6
Cahill, D.A.7
Goldstein, B.J.8
White, M.F.9
-
37
-
-
0022999337
-
Purification and characterization of the receptor for insulin-like growth factor 1
-
Morgan, D., K. Jarnagin, and R. Roth. 1986. Purification and characterization of the receptor for insulin-like growth factor 1. Biochemistry. 25: 5560-5564.
-
(1986)
Biochemistry
, vol.25
, pp. 5560-5564
-
-
Morgan, D.1
Jarnagin, K.2
Roth, R.3
-
38
-
-
0023946732
-
Insulin-like growth factor I binding in hepatocytes from human liver, human hepatoma, and normal, regenerating, and fetal rat liver
-
Caro, J.F., J. Poulos, O. Ittoop, W.J. Pories, E.G. Flickinger, and M.K. Sinha. 1988. Insulin-like growth factor I binding in hepatocytes from human liver, human hepatoma, and normal, regenerating, and fetal rat liver. J. Clin. Invest. 81:976-981.
-
(1988)
J. Clin. Invest.
, vol.81
, pp. 976-981
-
-
Caro, J.F.1
Poulos, J.2
Ittoop, O.3
Pories, W.J.4
Flickinger, E.G.5
Sinha, M.K.6
-
39
-
-
0030034219
-
Comparison of the time courses of insulin and the portal signal on hepatic glucose and glycogen metabolism in the conscious dog
-
Pagliassotti, M.J., L.C. Holste, M.C. Moore, D.W. Neal, and A.D. Cherrington. 1996. Comparison of the time courses of insulin and the portal signal on hepatic glucose and glycogen metabolism in the conscious dog. J. Clin. Invest. 97:81-91.
-
(1996)
J. Clin. Invest.
, vol.97
, pp. 81-91
-
-
Pagliassotti, M.J.1
Holste, L.C.2
Moore, M.C.3
Neal, D.W.4
Cherrington, A.D.5
-
40
-
-
0027247493
-
A low dose euglycemic infusion of recombinant human insulin-like growth factor I rapidly suppresses fasting-enhanced pulsatile growth hormone secretion in humans
-
Hartman, M., P. Clayton, M. Johnson, A. Celniker, A. Perlman, K. Alberti, and M. Thorner. 1993. A low dose euglycemic infusion of recombinant human insulin-like growth factor I rapidly suppresses fasting-enhanced pulsatile growth hormone secretion in humans. J. Clin. Invest. 91:2453-2462.
-
(1993)
J. Clin. Invest.
, vol.91
, pp. 2453-2462
-
-
Hartman, M.1
Clayton, P.2
Johnson, M.3
Celniker, A.4
Perlman, A.5
Alberti, K.6
Thorner, M.7
-
41
-
-
0028223994
-
Comparison of the metabolic effects of recombinant human insulin-like growth factor-I and insulin. Dose-response relationships in healthy young and middle-aged adults
-
Boulware, S.D., W.V. Tamborlane, N.J. Rennen, N. Gesundheit, and R.S. Sherwin. 1994. Comparison of the metabolic effects of recombinant human insulin-like growth factor-I and insulin. Dose-response relationships in healthy young and middle-aged adults. J. Clin. Invest. 93:1131-1139.
-
(1994)
J. Clin. Invest.
, vol.93
, pp. 1131-1139
-
-
Boulware, S.D.1
Tamborlane, W.V.2
Rennen, N.J.3
Gesundheit, N.4
Sherwin, R.S.5
-
42
-
-
1842358670
-
The effects of insulin-like growth factor-I on leucine and glucose kinetics in type II diabetes
-
McAloon-Dyke, M., N. Kukagawa, K. Minaker, H.-P. Guler, R. Wolfe, and D. Elahi. 1994. The effects of insulin-like growth factor-I on leucine and glucose kinetics in type II diabetes. Clin. Res. 42:118A.
-
(1994)
Clin. Res.
, vol.42
-
-
McAloon-Dyke, M.1
Kukagawa, N.2
Minaker, K.3
Guler, H.-P.4
Wolfe, R.5
Elahi, D.6
-
43
-
-
0027362462
-
Insulin-like growth factor I stimulates lipid oxidation, reduces protein oxidation, and enhances insulin sensitivity in humans
-
Hussain, M.A., O. Schmilz, A. Mengel, A. Keller, J.S. Christiansen, J. Zapf, and E.R. Froesch. 1993. Insulin-like growth factor I stimulates lipid oxidation, reduces protein oxidation, and enhances insulin sensitivity in humans. J. Clin. Invest. 92:2249-2256.
-
(1993)
J. Clin. Invest.
, vol.92
, pp. 2249-2256
-
-
Hussain, M.A.1
Schmilz, O.2
Mengel, A.3
Keller, A.4
Christiansen, J.S.5
Zapf, J.6
Froesch, E.R.7
-
44
-
-
0027074505
-
Insulin-like growth factor-I improves glucose and lipid metabolism in type 2 diabetes mellitus
-
Zenobi, P.D., G.S. Jaeggi, W.F. Riesen, M.E. Roder, and E.R. Froesch. 1992. Insulin-like growth factor-I improves glucose and lipid metabolism in type 2 diabetes mellitus. J. Clin. Invest. 90:2234-2241.
-
(1992)
J. Clin. Invest.
, vol.90
, pp. 2234-2241
-
-
Zenobi, P.D.1
Jaeggi, G.S.2
Riesen, W.F.3
Roder, M.E.4
Froesch, E.R.5
-
45
-
-
0029100402
-
Hormonal and nutritional regulation of liver fatty acid oxidation and ketogenesis during development
-
Prip-Buus, C., S. Thumelin, F. Chatelain, J.-P. Pegorier, and J. Girard. 1995. Hormonal and nutritional regulation of liver fatty acid oxidation and ketogenesis during development. Biochem. Soc. Trans. 23:500-506.
-
(1995)
Biochem. Soc. Trans.
, vol.23
, pp. 500-506
-
-
Prip-Buus, C.1
Thumelin, S.2
Chatelain, F.3
Pegorier, J.-P.4
Girard, J.5
-
46
-
-
0026600406
-
Hormonal control of fatty acid oxidation during the neonatal period
-
Pegorier, J.P., B.C. Prip, P.H. Duee, and J. Girard. 1992. Hormonal control of fatty acid oxidation during the neonatal period. Diabetes Metab. 18: 156-160.
-
(1992)
Diabetes Metab.
, vol.18
, pp. 156-160
-
-
Pegorier, J.P.1
Prip, B.C.2
Duee, P.H.3
Girard, J.4
-
47
-
-
0026537433
-
Adaptations of glucose and fatty acid metabolism during perinatal period and suckling-weaning transition
-
Girard, J., P. Ferre, J.P. Pegorier, and P.H. Duee. 1992. Adaptations of glucose and fatty acid metabolism during perinatal period and suckling-weaning transition. Physiol. Rev. 72:507-562.
-
(1992)
Physiol. Rev.
, vol.72
, pp. 507-562
-
-
Girard, J.1
Ferre, P.2
Pegorier, J.P.3
Duee, P.H.4
-
48
-
-
0028118369
-
Adverse effects of recombinant human insulin-like growth factor I in obese insulin-resistant type II diabetic patients
-
Jabri, N., D.S. Schalch, S.L. Schwanz, J.S. Fischer, M.S. Kipnes, B.J. Radnik, N.J. Turman, V.S. Marcsisin, and H.P. Guler. 1994. Adverse effects of recombinant human insulin-like growth factor I in obese insulin-resistant type II diabetic patients. Diabetes. 43:369-374.
-
(1994)
Diabetes
, vol.43
, pp. 369-374
-
-
Jabri, N.1
Schalch, D.S.2
Schwanz, S.L.3
Fischer, J.S.4
Kipnes, M.S.5
Radnik, B.J.6
Turman, N.J.7
Marcsisin, V.S.8
Guler, H.P.9
-
49
-
-
0025144452
-
IGF-I-stimulated glucose transport in human skeletal muscle and IGF-I resistance in obesity and NIDDM
-
Dohm, G.L., C.W. Elton, M.S. Raju, N.D. Mooney, R. DiMarchi, W.J. Pories, E.G. Flickinger, S.J. Atkinson, and J.F. Caro. 1990. IGF-I-stimulated glucose transport in human skeletal muscle and IGF-I resistance in obesity and NIDDM. Diabetes. 39:1028-1032.
-
(1990)
Diabetes
, vol.39
, pp. 1028-1032
-
-
Dohm, G.L.1
Elton, C.W.2
Raju, M.S.3
Mooney, N.D.4
DiMarchi, R.5
Pories, W.J.6
Flickinger, E.G.7
Atkinson, S.J.8
Caro, J.F.9
-
50
-
-
0026740625
-
Simultaneous insulinlike growth factor I and insulin resistance in obese Zucker rats
-
Jacob, R.J., R.S. Sherwin, K. Greenawalt, and G.I. Shulman. 1992. Simultaneous insulinlike growth factor I and insulin resistance in obese Zucker rats. Diabetes. 41:691-697.
-
(1992)
Diabetes
, vol.41
, pp. 691-697
-
-
Jacob, R.J.1
Sherwin, R.S.2
Greenawalt, K.3
Shulman, G.I.4
-
51
-
-
1842384647
-
Therapeutic trial of IGF-1 in a patient with Donohue syndrome
-
Las Vegas, NV. The Endocrine Society. Bethesda, MD
-
Backeljauw, P., and M. Davenport. 1993. Therapeutic trial of IGF-1 in a patient with Donohue syndrome. Prog. Annu. Mtg. Endocr. Soc. 1320. Las Vegas, NV. The Endocrine Society. Bethesda, MD.
-
(1993)
Prog. Annu. Mtg. Endocr. Soc. 1320
-
-
Backeljauw, P.1
Davenport, M.2
-
52
-
-
0028091483
-
Effect of intravenous insulin-like growth factor I in two patients with leprechaunism
-
Backeljauw, P.F., C. Alves, M. Eidson, W. Cleveland, L.E. Underwood, and M.L. Davenport. 1994. Effect of intravenous insulin-like growth factor I in two patients with leprechaunism. Pediatr. Res. 36:749-754.
-
(1994)
Pediatr. Res.
, vol.36
, pp. 749-754
-
-
Backeljauw, P.F.1
Alves, C.2
Eidson, M.3
Cleveland, W.4
Underwood, L.E.5
Davenport, M.L.6
-
53
-
-
1842388576
-
IGF-1 treatment of severely insulin resistant child with short stature and diabetes mellitus
-
Las Vegas, NV. The Endocrine Society. Bethesda, MD
-
Hone, J., M. Skarulis, D. Donaldson, C. Cochran, and R. Eastman. 1993. IGF-1 treatment of severely insulin resistant child with short stature and diabetes mellitus. Prog. Annu. Mtg. Endocr. Soc. 1319. Las Vegas, NV. The Endocrine Society. Bethesda, MD.
-
(1993)
Prog. Annu. Mtg. Endocr. Soc. 1319
-
-
Hone, J.1
Skarulis, M.2
Donaldson, D.3
Cochran, C.4
Eastman, R.5
-
54
-
-
0027288789
-
Treatment of type A insulin resistance with insulin-like growth factor-I
-
Hussain, M.A., and E.R. Froesch. 1993. Treatment of type A insulin resistance with insulin-like growth factor-I. Lancet. 341:1536-1537.
-
(1993)
Lancet
, vol.341
, pp. 1536-1537
-
-
Hussain, M.A.1
Froesch, E.R.2
-
55
-
-
0027245458
-
Trial of insulin-like growth factor I therapy for patients with extreme insulin resistance syndromes
-
Kuzuya, H., N. Matsuura, M. Sakamoto, H. Makino, Y. Sakamoto, T. Kadowaki, Y. Suzuki, M. Kobayashi, Y. Akazawa, M. Nomura, et al. 1993. Trial of insulin-like growth factor I therapy for patients with extreme insulin resistance syndromes. Diabetes. 42:696-705.
-
(1993)
Diabetes
, vol.42
, pp. 696-705
-
-
Kuzuya, H.1
Matsuura, N.2
Sakamoto, M.3
Makino, H.4
Sakamoto, Y.5
Kadowaki, T.6
Suzuki, Y.7
Kobayashi, M.8
Akazawa, Y.9
Nomura, M.10
-
56
-
-
0025200572
-
Acute response to recombinant insulin-like growth factor I in a patient with Mendenhall's syndrome
-
Quin, J.D., B.M. Fisher, K.R. Paterson, A. Inoue, G.H. Beastall, and A.C. MacCuish. 1990. Acute response to recombinant insulin-like growth factor I in a patient with Mendenhall's syndrome. N. Engl. J. Med. 323:1425-1426.
-
(1990)
N. Engl. J. Med.
, vol.323
, pp. 1425-1426
-
-
Quin, J.D.1
Fisher, B.M.2
Paterson, K.R.3
Inoue, A.4
Beastall, G.H.5
MacCuish, A.C.6
-
57
-
-
0030894965
-
A homozygous kinase-defective mutation in the insulin receptor gene in a patient with leprechaunism
-
Takahashi, Y., H. Kadowaki, K. Momomura, Y. Fukushima, T. Orban, T. Okai, Y. Taketani, Y. Akanuma, Y. Yazaki, and T. Kadowaki. 1997. A homozygous kinase-defective mutation in the insulin receptor gene in a patient with leprechaunism. Diabetologia. 40:412-420.
-
(1997)
Diabetologia
, vol.40
, pp. 412-420
-
-
Takahashi, Y.1
Kadowaki, H.2
Momomura, K.3
Fukushima, Y.4
Orban, T.5
Okai, T.6
Taketani, Y.7
Akanuma, Y.8
Yazaki, Y.9
Kadowaki, T.10
|